Treatment is not always warranted for older men with prostate cancer and a short life expectancy, Yale School of Medicine researchers report in the Feb. 27 Archives of Internal Medicine.
- Social Sciences - Apr 22 Focus of Penn Researcher Leads to National Summit on Youth Aging Out of Foster Care
- Life Sciences - Apr 22 Penn Bioinformatics Profiling Identifies a New Mammalian Clock Gene
- Environmental Sciences - Apr 22 UAlberta one of Canada’s Greenest Employers for sixth straight year April 22, 2014 Green award recognizes leadership in creating culture of environmental awareness
- Literature - Apr 22 'A rarity most beloved': Shakespeare folios on display
- Chemistry - Apr 22 Cornell's chemically engineered cars win again
- Life Sciences - Apr 22 New alfalfa variety resists ravenous local pest
- Arts - Apr 22 Stanford Live posts 2014-15 season performances
- Life Sciences - Apr 22 Scientists observe brain activity in real time
- Environmental Sciences - Apr 22 Birding Cup, Native Plant Festival take flight at Shaver’s Creek on May 2 and 3
- History - Apr 22 Exhibit explores the art and science of bones found on the Green
- Life Sciences - Apr 22 'OMG GMO' will look at the science behind genetically modified food
Prostate cancer treatment overused in some older patients
"Treatment can do more harm than good in some instances," said senior author on the study Cary Gross , associate professor of internal medicine at Yale School of Medicine. "Among men who are older and have less aggressive forms of prostate cancer, their cancer is unlikely to progress or cause them harm in their remaining years."
Gross and his team analyzed nine years of Medicare data and found that over the past decade, there has been a trend towards higher use of curative treatment for prostate cancer among men with certain types of tumors and a short life expectancy. The study included 39,270 patients between the ages of 67 and older.
These results suggest that cancer treatment was increasingly aggressive in patients who had the lowest likelihood of seeing clinical benefits, Gross said, noting that while not treating potentially fatal cancer can reflect poor-quality care, aggressively managing disease that is unlikely to progress puts patients at risk for complications and increases costs without medical benefits.
"We found that the percentage of men who received treatment for their prostate cancer treatments increased over time from 61.2% to 67.6% from 1998 through 2007," said Gross, who is a member of Yale Cancer Center. "However, we were surprised to find that the biggest increase was among men with moderate-risk prostate cancer who had the shortest life expectancy. On the other hand, cancer treatment decreased among men with low-risk tumors and longer life expectancy."
Treating patients with shorter life expectancy may add costs or complications without contributing to quality of life, he said. The National Comprehensive Cancer Network practice guidelines in oncology recommend actively monitoring patients as an alternative to medication for patients with less aggressive tumor types and shorter life expectancies.
Gross said that the use of cancer therapies should be guided by clinical evidence and patient preferences. "Future work should explore how better to incorporate both cancer characteristics and patient life expectancy into decision making," said Gross.
Other authors on the study included Ann c. Raldow, M.D., Carolyn J. Presley, M.D., James B. Yu, M.D., Richa Sharma, Pamela R. Soulos, Jessica B. Long, and Danil V. Makarov, M.D.
The National Cancer Institute and the James G. Hirsch Medical Student Research Fellowship funded the study.
Citation: Arch. Inter. Med. Vol. 172, No. 4 (February 27, 2012)
Last job offers
- Medicine - 23.4
Asst/Assoc / Professor of Clinical Medicine (Infectious Disease)
- Medicine - 23.4
Assistant / Associate Professor - Pediatric Emergency Medicine
- Psychology - 22.4
Tenure-related Open Rank Faculty Position
- Life Sciences - 22.4
Assistant Professor / Faculty Position
- Medicine - 21.4
Assistant / Associate/Full Professor of Clinical Neurosurgery
- Medicine - 21.4
Associate or Full Professor
- Medicine - 19.4
- Medicine - 18.4
Infectious Diseases ct Faculty Position